Clinical trial
A 12-Week, Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of LY2599506 in Patients With Type 2 Diabetes Mellitus Treated With Diet and Exercise, With or Without Metformin
NCT01024244 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A 12-Week, Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of LY2599506 in Patients With Type 2 Diabetes Mellitus Treated With Diet and Exercise, With or Without Metformin
- Lead sponsor
- Eli Lilly and Company
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- December 31, 2009
- Completion date
- July 31, 2010
- Enrollment
- 78 (actual)
- Sites
- 16
Conditions
As the registry lists them; a condition with its own page is linked.